ES555246A0 - Procedimiento para la preparacion de compuestos de actividad antibacteriana - Google Patents

Procedimiento para la preparacion de compuestos de actividad antibacteriana

Info

Publication number
ES555246A0
ES555246A0 ES555246A ES555246A ES555246A0 ES 555246 A0 ES555246 A0 ES 555246A0 ES 555246 A ES555246 A ES 555246A ES 555246 A ES555246 A ES 555246A ES 555246 A0 ES555246 A0 ES 555246A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
antibacterial activity
activity compounds
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES555246A
Other languages
English (en)
Other versions
ES8707188A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schering SpA
Original Assignee
Schering SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering SpA filed Critical Schering SpA
Publication of ES555246A0 publication Critical patent/ES555246A0/es
Publication of ES8707188A1 publication Critical patent/ES8707188A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES555246A 1985-05-10 1986-05-09 Procedimiento para la preparacion de compuestos de actividad antibacteriana Expired ES8707188A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20653/85A IT1200470B (it) 1985-05-10 1985-05-10 Composti ad attivita' antibatterica,loro preparazione e composizioni farmaceutiche relative

Publications (2)

Publication Number Publication Date
ES555246A0 true ES555246A0 (es) 1987-07-16
ES8707188A1 ES8707188A1 (es) 1987-07-16

Family

ID=11170084

Family Applications (1)

Application Number Title Priority Date Filing Date
ES555246A Expired ES8707188A1 (es) 1985-05-10 1986-05-09 Procedimiento para la preparacion de compuestos de actividad antibacteriana

Country Status (6)

Country Link
JP (1) JPS61277668A (es)
DE (1) DE3615303A1 (es)
ES (1) ES8707188A1 (es)
FR (1) FR2583418A1 (es)
GB (1) GB2174704A (es)
IT (1) IT1200470B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5624671B2 (es) * 1973-07-05 1981-06-08
JPS5824438B2 (ja) * 1974-02-12 1983-05-20 大日本製薬株式会社 2−(1− ピペラジニル ) ピリド (2,3−d) ピリミジンユウドウタイノセイホウ
DE2903850A1 (de) * 1979-02-01 1980-08-07 Bayer Ag 2-amino-8-cyclopropyl-5-oxo-5,8- dihydro-pyrido eckige klammer auf 2,3-d eckige klammer zu -pyrimidin-6-carnonsaeuren, verfahren zu ihrer herstellung sowie ihrer verwendung als antibakterielle mittel
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3306772A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinolonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3308908A1 (de) * 1983-03-12 1984-09-13 Bayer Ag, 5090 Leverkusen Bakterizide mittel
NZ208470A (en) * 1983-07-18 1988-06-30 Abbott Lab 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such

Also Published As

Publication number Publication date
JPS61277668A (ja) 1986-12-08
GB2174704A (en) 1986-11-12
FR2583418A1 (fr) 1986-12-19
DE3615303A1 (de) 1986-11-13
IT1200470B (it) 1989-01-18
GB8610985D0 (en) 1986-06-11
ES8707188A1 (es) 1987-07-16
IT8520653A0 (it) 1985-05-10

Similar Documents

Publication Publication Date Title
AR241014A1 (es) "procedimiento para la preparacion de feniletanolami-notetralinas de actividad lipolitica"
ES553138A0 (es) Procedimiento para la preparacion de 3-ariluracilos
ES551625A0 (es) Procedimiento para la preparacion de 13-alquil-ll b -fenil-gonamos
ES539486A0 (es) Procedimiento para la preparacion de compuestos cotelomeros
ES547951A0 (es) Procedimiento para la preparacion de nuevas benzoilfenilu- reas
MX163569B (es) Procedimiento para la preparacion de benzoil-ureas
ES547924A0 (es) Procedimiento para la preparacion de bencileteres sustitui- dos
ES556598A0 (es) Procedimiento para la preparacion de derivados de 13beta-alquil-milbemicina
MX162421A (es) Procedimiento para la preparacion de n-acilfenilalaninas
MX162552A (es) Procedimiento para la preparacion de benzoil-ureas
ES554942A0 (es) Procedimiento para la obtencion de nuevos compuestos de piridazinio
ES541906A0 (es) Procedimiento para la preparacion de glicidiloxidicetonas
ES542071A0 (es) Procedimiento para la preparacion de ergolinas
MX162939B (es) Procedimiento mejorado para la preparacion de monoterbutiltolueno-diamina
ES553986A0 (es) Procedimiento para la obtencion de compuestos de heterociclil-penem
MX11650A (es) Procedimiento para la preparacion de compuestos denaftil-azo-pirazolona
ES531159A0 (es) Procedimiento para la preparacion de aminociclotiadiazinas
ES555246A0 (es) Procedimiento para la preparacion de compuestos de actividad antibacteriana
ES557233A0 (es) Procedimiento para la preparacion de 3-ariluracilos
MX7420E (es) Procedimiento para la preparacion de carbamoil-lactama-n-substituida
ES549829A0 (es) Procedimiento para la preparacion de carbazatos
ES549163A0 (es) Procedimiento para la preparacion de la 1-cinamil-4- benzi- drilpiperazina
ES555439A0 (es) Procedimiento para la fabricacion de compuestos hidroximetilcefem
ES540352A0 (es) Procedimiento para la preparacion de compuestos derivados deguanidinotiazol
ES541017A0 (es) Procedimiento para la preparacion de propanolaminas